19. 12. 2002
|
DEAR SHAREHOLDERS,
Press releases in 2002
29. 11. 2002
|
Ljubljana, 29 November 2002 – The Slovenian pharmaceutical company Lek d.d. received another final approval from the US regulatory authorities (Food and Drug Administration) ...
29. 11. 2002
|
Ljubljana, 29 November 2002 – The new strategic alliance of Lek Pharmaceuticals d.d. represents yet another milestone in the company’s development. By maintaining its ...
26. 11. 2002
|
Ljubljana, 26 November 2002 – The Slovenian pharmaceutical company Lek d.d. received final approval from the US regulatory authorities (Food and Drug Administration) to ...
26. 11. 2002
|
In accordance with Article 50 of the Takeovers Act, with Article 66 of the Securities Market Act, and with the Rules of the Ljubljana ...
22. 11. 2002
|
RESULT OF THE BID ISSUED BY COMPANY SERVIPHARM AG, BASEL, SWITZERLAND FOR PURCHASE OF ...
Novartis successfully completes friendly public offer for Lek, with more than 99% of shares tendered
21. 11. 2002
|
Deal positions Novartis Generics as a leader in the extended European market including the Eastern and South Eastern Europe and CIS region.
...
18. 11. 2002
|
The pharmaceutical company Lek, Verovskova 57, 1526 Ljubljana, in accord with the provisions of article 66 of the ZTVP and the Rules of ...
12. 11. 2002
|
Ljubljana, 12 November 2002 – Lek Pharmaceuticals d.d. announces that at the 17th General Meeting held today its shareholders adopted the proposed resolutions that ...
30. 10. 2002
|
In accordance with the provisions of Article 66 of the Securities Market Act and with the Rules of the Ljubljana Stock Exchange, Lek Pharmaceuticals ...
30. 10. 2002
|
26% sales growth of Lek d.d. and of Lek Group in the first 9 months of 2002
22. 10. 2002
|
In accordance with the provisions of Article 66 of the Securities Market Act and with the Rules of the Ljubljana Stock Exchange, Lek Pharmaceuticals ...
21. 10. 2002
|
In accordance with the provisions of Article 66 of the Securities Market Act and with the Rules of the Ljubljana Stock Exchange d.d., Lek ...
21. 10. 2002
|
On the basis of the request made by the minority of Lek shareholders (Pension Fund Management d.d., Ljubljana, Slovenian Restitution Fund d.d., Ljubljana,
5. 10. 2002
|
Based on the provisions of Article 25 of the Takeover Act (Official Gazette of the Republic of Slovenia No. 47/97 and 56/99) the Board ...
1. 10. 2002
|
Ljubljana, 1 October 2002 – Lek Pharmaceuticals d.d., Verovškova 57, Ljubljana, hereby announces that its subsidiary Lek Zagreb d.o.o., Maksimirska 120, Zagreb, Croatia, has ...
30. 9. 2002
|
In accordance with the provisions of the Securities Market Act-1 and the Rules of the Ljubljana Stock Exchange d.d., Ljubljana Lek Pharmaceuticals d.d., Verovškova ...
27. 9. 2002
|
Lek Pharmaceuticals d. d. announces that the resolutions proposed at today’s Extraordinary General Meeting of shareholders have not been approved. In the announcement regarding ...
29. 8. 2002
|
Novartis intends, subject to certain conditions, to make an offer to acquire all of the capital stock of Lek for 95,000 Slovenian Tolars ...
28. 8. 2002
|
In accordance with the Rules of the Ljubljana Stock Exchange , d.d., Ljubljana, and with Article 66 of the Securities Market Act – 1, ...
14. 8. 2002
|
Lendava, August 13 – The Lendava Waste Water Treatment Plant (WWTP) officially commenced operation in August 2001, and on July 17 it signed ...
5. 8. 2002
|
Ljubljana, 5 August – This year’s semiannual sales of the Lek Group amounted to SIT 46 billion, a 23% increase compared with the ...
15. 7. 2002
|
Ljubljana – The US Food and Drug Administration has completed a comprehensive inspection of several of the Company’s facilities during the period of June ...
8. 7. 2002
|
Ljubljana, Targu Mures, 8 July 2002 – The Slovenian pharmaceutical company Lek d.d. laid the foundation stone of the new production plant in Romania ...
2. 7. 2002
|
Ljubljana, July 1 – The Slovenian pharmaceutical company Lek announces that it has received final approval from U.S. regulatory authorities to immediately start the ...
28. 6. 2002
|
Ljubljana, 24 June; The 15th Annual General Meeting took place today at the premises of Lek d. d. The shareholders discussed and supported the ...
26. 6. 2002
|
Prevalje, 25 June – Upon Slovenia’s National Day and the Prevalje municipal holiday, Metod Dragonja, President of Lek Board of Management, delivered the keys ...
6. 6. 2002
|
Ljubljana, June 4 – Recently, the media reporting on the events in the Stock Exchange and in the economy have frequently mentioned the company ...
6. 5. 2002
|
Ljubljana, May 6, 2002 – Today, with the president of the Republic of Slovenia, Milan Kučan, and prominent representatives of the Slovenian scientific and ...
24. 4. 2002
|
Lendava, April 23 – The pharmaceutical company Lek d. d., hosted many visitors from the Lendava neighborhood. By holding an open house today at ...
8. 4. 2002
|
On Monday, 8 April 2002, the business daily Finance granted for the third year running awards to the company ranking highest on the Stock ...
27. 3. 2002
|
Ljubljana, March 27- Today, the Slovenian pharmaceutical company Lek officially opened a completely renovated production plant in Ljubljana for the manufacture of sterile products. ...
27. 3. 2002
|
Ljubljana, March 27 – The Slovenian pharmaceutical company Lek exceeded expectations and projected goals for the year 2001. Accordingly, the Executive Board, meeting on ...
28. 1. 2002
|
Ljubljana, January 31 – The Slovenian pharmaceutical company Lek announces that it has received approval from US regulatory authorities to immediately market the dopamine ...
28. 1. 2002
|
Ljubljana, January 28 – The Slovenian pharmaceutical company Lek exceeded its sales objectives in 2001. In that period, Lek sales reached SIT 68 ...
23. 1. 2002
|
Starting January 1, 2002, Lek Kozmetika began operations as a completely independent daughter company of the pharmaceutical firm Lek. The Cosmetics Unit used to ...
14. 1. 2002
|
It is people that build today and tomorrow’s Lek. We are pleased to announce the following promotions to Managing Directors:
